JP2018513868A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018513868A5 JP2018513868A5 JP2017555374A JP2017555374A JP2018513868A5 JP 2018513868 A5 JP2018513868 A5 JP 2018513868A5 JP 2017555374 A JP2017555374 A JP 2017555374A JP 2017555374 A JP2017555374 A JP 2017555374A JP 2018513868 A5 JP2018513868 A5 JP 2018513868A5
- Authority
- JP
- Japan
- Prior art keywords
- agents
- virus
- compound
- drugs
- mammal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 0 Cc1c(*)cn[o]1 Chemical compound Cc1c(*)cn[o]1 0.000 description 4
- ADGOPPKEIZXKAZ-UHFFFAOYSA-N Cc1c(-c2cc(-c3ccnc(Nc4cc(NC(c5ccc(CN6CCN(C)CC6)cc5)=O)ccc4C)n3)cnc2)[o]nc1 Chemical compound Cc1c(-c2cc(-c3ccnc(Nc4cc(NC(c5ccc(CN6CCN(C)CC6)cc5)=O)ccc4C)n3)cnc2)[o]nc1 ADGOPPKEIZXKAZ-UHFFFAOYSA-N 0.000 description 1
- OWBTYLSRODUZAK-UHFFFAOYSA-N Cc1c(C(N)=O)[nH]nc1 Chemical compound Cc1c(C(N)=O)[nH]nc1 OWBTYLSRODUZAK-UHFFFAOYSA-N 0.000 description 1
- VQTVFIMEENGCJA-UHFFFAOYSA-N Cc1c(C)[nH]nc1 Chemical compound Cc1c(C)[nH]nc1 VQTVFIMEENGCJA-UHFFFAOYSA-N 0.000 description 1
- BSWGZCMLNFBDEZ-UHFFFAOYSA-N Cc1c(C)[o]nc1 Chemical compound Cc1c(C)[o]nc1 BSWGZCMLNFBDEZ-UHFFFAOYSA-N 0.000 description 1
- PSOZJOZKEVZLKZ-UHFFFAOYSA-N Cc1c[o]c(C)n1 Chemical compound Cc1c[o]c(C)n1 PSOZJOZKEVZLKZ-UHFFFAOYSA-N 0.000 description 1
- KBOSIRPMGVGOEP-UHFFFAOYSA-N Cc1cc(C(N)=O)n[o]1 Chemical compound Cc1cc(C(N)=O)n[o]1 KBOSIRPMGVGOEP-UHFFFAOYSA-N 0.000 description 1
- FICAQKBMCKEFDI-UHFFFAOYSA-N Cc1n[o]c(C)c1 Chemical compound Cc1n[o]c(C)c1 FICAQKBMCKEFDI-UHFFFAOYSA-N 0.000 description 1
- OBFUZQPNGSXDLY-UHFFFAOYSA-N Cc1nc(C(N)=O)c[o]1 Chemical compound Cc1nc(C(N)=O)c[o]1 OBFUZQPNGSXDLY-UHFFFAOYSA-N 0.000 description 1
- XEFYPTQOROORRU-UHFFFAOYSA-N Cc1ncc(C(N)=O)[o]1 Chemical compound Cc1ncc(C(N)=O)[o]1 XEFYPTQOROORRU-UHFFFAOYSA-N 0.000 description 1
- YVDWFZIVIIKYBQ-UHFFFAOYSA-N Cc1nnc(C)[o]1 Chemical compound Cc1nnc(C)[o]1 YVDWFZIVIIKYBQ-UHFFFAOYSA-N 0.000 description 1
- ZMSIFDIKIXVLDF-UHFFFAOYSA-N Cc1nnc[o]1 Chemical compound Cc1nnc[o]1 ZMSIFDIKIXVLDF-UHFFFAOYSA-N 0.000 description 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562151659P | 2015-04-23 | 2015-04-23 | |
| US62/151,659 | 2015-04-23 | ||
| US201562182955P | 2015-06-22 | 2015-06-22 | |
| US62/182,955 | 2015-06-22 | ||
| PCT/US2016/028914 WO2016172528A1 (en) | 2015-04-23 | 2016-04-22 | Compositions and methods for inhibiting kinases |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018513868A JP2018513868A (ja) | 2018-05-31 |
| JP2018513868A5 true JP2018513868A5 (enExample) | 2019-05-23 |
| JP6795518B2 JP6795518B2 (ja) | 2020-12-02 |
Family
ID=57144281
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017555374A Active JP6795518B2 (ja) | 2015-04-23 | 2016-04-22 | キナーゼを阻害する組成物及び方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (8) | US9828370B2 (enExample) |
| EP (1) | EP3286179A4 (enExample) |
| JP (1) | JP6795518B2 (enExample) |
| AU (2) | AU2016252860B2 (enExample) |
| CA (1) | CA2980478C (enExample) |
| WO (1) | WO2016172528A1 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2016252860B2 (en) | 2015-04-23 | 2020-09-17 | Inhibikase Therapeutics, Inc. | Compositions and methods for inhibiting kinases |
| WO2018081251A1 (en) * | 2016-10-25 | 2018-05-03 | Inhibikase Therapeutics, Inc. | Compositions and methods for inhibiting kinases |
| US10855891B2 (en) | 2016-11-21 | 2020-12-01 | Samsung Electro-Mechanics Co., Ltd. | Apparatus for controlling position of camera module |
| TW202039862A (zh) * | 2018-11-12 | 2020-11-01 | 美商藍印藥品公司 | 受體酪氨酸激酶(kit)基因突變 |
| JP2022523562A (ja) * | 2019-03-05 | 2022-04-25 | ホンイー アンド アソシエイツ エルエルシー | 神経変性疾患および癌の治療のための化合物 |
| CN115645393A (zh) * | 2020-02-26 | 2023-01-31 | 上海科技大学 | 二氢杨梅素在抗冠状病毒中的应用 |
| EP4138847A4 (en) * | 2020-04-24 | 2024-05-22 | Memorial Sloan Kettering Cancer Center | Targeted therapy for the treatment & prevention of life-threatening complications of infection |
| CN112552283A (zh) * | 2020-12-07 | 2021-03-26 | 天津羲泽润科技有限公司 | 一种新型替尼类药物的制备方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1805748B (zh) * | 2003-06-13 | 2010-05-26 | 诺瓦提斯公司 | 作为raf激酶抑制剂的2-氨基嘧啶衍生物 |
| CA2662677C (en) * | 2006-09-05 | 2016-05-31 | Emory University | Kinase inhibitors for preventing or treating pathogen infection and method of use thereof |
| WO2008070350A2 (en) * | 2006-10-27 | 2008-06-12 | The Board Of Regents Of The University Of Texas System | Methods and compositions related to wrapping of dehydrons |
| CN102406648A (zh) | 2010-09-21 | 2012-04-11 | 中国科学院生物物理研究所 | 甲磺酸伊马替尼在制备抗帕金森病药物中的应用 |
| KR20150008406A (ko) | 2012-05-15 | 2015-01-22 | 노파르티스 아게 | Abl1, abl2 및 bcr-abl1의 활성을 억제하기 위한 벤즈아미드 유도체 |
| WO2014055938A1 (en) | 2012-10-04 | 2014-04-10 | Inhibikase Therapeutics, Inc. | Novel compounds, their preparation and their uses |
| AU2016252860B2 (en) | 2015-04-23 | 2020-09-17 | Inhibikase Therapeutics, Inc. | Compositions and methods for inhibiting kinases |
| WO2018081251A1 (en) | 2016-10-25 | 2018-05-03 | Inhibikase Therapeutics, Inc. | Compositions and methods for inhibiting kinases |
-
2016
- 2016-04-22 AU AU2016252860A patent/AU2016252860B2/en active Active
- 2016-04-22 EP EP16783966.1A patent/EP3286179A4/en active Pending
- 2016-04-22 CA CA2980478A patent/CA2980478C/en active Active
- 2016-04-22 JP JP2017555374A patent/JP6795518B2/ja active Active
- 2016-04-22 US US15/136,497 patent/US9828370B2/en active Active
- 2016-04-22 WO PCT/US2016/028914 patent/WO2016172528A1/en not_active Ceased
-
2017
- 2017-11-07 US US15/805,693 patent/US10118923B2/en active Active
-
2018
- 2018-10-24 US US16/169,683 patent/US10344027B2/en active Active
- 2018-10-24 US US16/169,677 patent/US10316031B2/en active Active
-
2019
- 2019-06-26 US US16/452,828 patent/US10906896B2/en active Active
-
2020
- 2020-12-14 AU AU2020286339A patent/AU2020286339B2/en active Active
-
2021
- 2021-01-05 US US17/141,825 patent/US11407747B2/en active Active
-
2022
- 2022-06-24 US US17/849,141 patent/US11725005B2/en active Active
-
2024
- 2024-09-24 US US18/894,338 patent/US20250250266A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018513868A5 (enExample) | ||
| US9271984B2 (en) | Treatment of type 1 diabetes | |
| CN114727999A (zh) | 用于预防hiv的衣壳抑制剂 | |
| FI3908270T3 (fi) | Faanin ja bupropionin yhdistelmä masennuksen hoitoon aasialaisilla potilailla | |
| RU2017114352A (ru) | АНТАГОНИСТЫ ИНТЕГРИНА ανβ6 | |
| JP2018510178A5 (enExample) | ||
| EA026074B1 (ru) | Способы, включающие применение композиции амбризентана и тадалафила для лечения легочной артериальной гипертензии | |
| CZ20033115A3 (cs) | Léčivo pro léčení a/nebo profylaxi stavů charakterizovaných změněnou funkcí střev a/nebo viscerální bolestí | |
| BRPI0609952A2 (pt) | métodos para modular a função da bexiga | |
| RU2019135261A (ru) | Фармацевтическая композиция, содержащая ингибитор pde9 | |
| JP2009525265A5 (enExample) | ||
| US20200147081A1 (en) | Use of Kinase Inhibitors to Manage Tuberculosis and Other Infectious Diseases | |
| RU2017127509A (ru) | Композиции и способы для улучшенного мышечного метаболизма | |
| DE69412662T2 (de) | Angiotensin II-Antagonisten zur Behandlung von viralen Erkrankungen | |
| RU2005129333A (ru) | 4-[(2,4-дихлор-5-метоксифенил)амино]-6-алкокси-3-хинолинкарбонитрилы для лечения ишемического повреждения | |
| EA012630B1 (ru) | Комбинация феррохина и производного артемизинина для лечения малярии | |
| US9867789B2 (en) | Non-steroidal anti-inflammatory drugs for cough | |
| KR102879944B1 (ko) | Hiv 예방용 인테그라제 억제제 | |
| RU2007132971A (ru) | Способы и материалы с транс-кломифеном для лечения мужского бесплодия | |
| CN109172550B (zh) | 一种复合麻醉药物 | |
| MX2022006404A (es) | Composicion farmaceutica para el tratamiento de la enfermedad vascular pulmonar y/o disfuncion cardiaca en pacientes paliados con fontan. | |
| JP2011514319A (ja) | 急性マラリアを治療するためのビス−チアゾリウム塩またはこれらの前駆体およびアルテミシニンまたはこれらの誘導体の組み合わせ | |
| US20060128719A1 (en) | Use of alpha-adrenergic blockers for the treatment of dysmenorrhea | |
| FI3947384T3 (fi) | Isokromeenijohdannaisia fosfoinositidi-3-kinaasien estäjinä | |
| JP2006008540A (ja) | 風邪薬 |